An extremely common condition rising at an alarming rate due to environmental and lifestyle causal elements, respiratory disease is the third leading cause of death worldwide. Despite the copious amounts … Continue Reading Severely damaged human lungs successfully recovered using transgenic system.
In the past chimeras, an unnatural amalgamation of two different species was the stuff of futuristic sci-fiction comics, today this promising genetic engineering technique is less scary as it becomes … Continue Reading First pig-monkey chimera engineered and born.
Researchers in the field of evolutionary development have long sought to understand how genetic mutations millions of years ago changed embryonic development to yield the diverse animal forms seen today. … Continue Reading Researchers de-extinct flies with ancient genes to study evolution.
One infant in every 1000 is diagnosed with sensorineural hearing loss, making it an extremely common hereditary disease. It is also estimated that 25-40% of over-65s suffer from acquired sensorineural … Continue Reading Large-scale study identifies the causative gene for sensorineural hearing.
The power plants that fuel liver cells rapidly splinter when exposed to bile salts that aid digestion, prompting cell death, but blocking this excessive fission appears to protect the liver, … Continue Reading Controlling mitochondria cell-division reduces liver cell death in cholestasis.
An organism is healthy thanks to a good maintenance system; the normal functioning of organs and environmental exposure cause damage to tissues, which need to be continuously repaired. This process … Continue Reading CNIO researchers discover a gene that links stem cells, aging and cancer.
Discovery of new drug targets for memory impairment in Alzheimer’s Disease. A study from KIST has revealed the novel mechanism of how Alzheimer’s patients might lose their memory. The researchers also propose new therapeutic targets, which include GABA production and release mechanisms in reactive astrocytes for treatment of Alzheimer’s disease. Furthermore, we provide a stepping stone for the development of MAO-B inhibitors with long lasting efficacy.
Thoughts health innovators?